Epstein-Barr Virus Based Expression Vectors

  • R. F. Margolskee
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 158)


Eukaryotic viral vectors have played an important role in the expression and analysis of many eukaryotic genes. The field is growing at a rapid pace and is by no means mature (for contrast see the reports from the first and second Banbury Conferences on Eukaryotic Viral Vectors, Gluzman 1982; Gluzman and Hughes 1988). Although in theory it should be possible to develop a eukaryotic vector from any virus, practical considerations have led to concentration on a few well-characterized viruses, e.g., papovaviruses, adenoviruses, herpesviruses, and retroviruses. As the understanding of the underlying biology of the virus’ life cycle has matured, so too has the sophistication of specific virus based vectors. Frequently the development of virus vectors has been instrumental in dissecting the functional elements of the parent virus. Present-day eukaryotic vectors are a collection of eukaryotic elements from many different cellular and viral sources. Unfortunately, there are no simple rules for constructing the best eukaryotic vector, hence much of this field has developed from empirical trials. Furthermore, no single vector presently exists that provides a solution for all situations that require a eukaryotic vector.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams A (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61: 1743–1746PubMedGoogle Scholar
  2. Adams A, Lindahl T (1975) Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72: 1477–1481PubMedCrossRefGoogle Scholar
  3. Ashman CR, Davidson RL (1985) High spontaneous mutation frequency of BPV shuttle vector. Somate Cell Mol Genet 11: 499–504CrossRefGoogle Scholar
  4. Baer B, Bankier A, Biggin M, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95–8 Epstein-Barr virus genome. Nature 310: 207–211PubMedCrossRefGoogle Scholar
  5. Baichwal VR, Sugden B (1988) Latency comes of age for herpesviruses. Cell 52: 787–789PubMedCrossRefGoogle Scholar
  6. Birx DL, Redfield RR, Tosato G (1986) Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 314: 874–879PubMedCrossRefGoogle Scholar
  7. Bodescot M, Perricaudet M (1986) Epstein-Barr virus mRNA produced by alternative splicing. Nucleic Acids Res 14: 7103–7114PubMedCrossRefGoogle Scholar
  8. Bodescot M, Brison O, Pericaudet M (1986) Epsten-Barr virus transcription unit is at least 84 kilobases long. Nucleic Acids Res 14: 2611–2620PubMedCrossRefGoogle Scholar
  9. Bodescot M, Perricaudet M, Farrell PJ (1987) A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J Virol 61: 3424–3430PubMedGoogle Scholar
  10. Calos MP, Lebkowski JS, Botchan MR (1983) High mutation frequency in DNA transfected into mammalian cells. Proc Natl Acad Sci USA 80: 3015–3019PubMedCrossRefGoogle Scholar
  11. Canfield V, Emanuel JR, Spickofsky N, Levenson R, Margolskee RF (1990) Ouabain resistant mutants of the rat Na, K-ATPase α2 isoform identified using an episomal expression vector. Mol Cell Biol 10: 1367–1372PubMedGoogle Scholar
  12. Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A (1986) Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5: 3243–3249PubMedGoogle Scholar
  13. Chittenden T, Lupton S, Levine A (1989) Functional limits of ori P, the Epstein-Barr virus plasmid origin of replication. J Virol 63: 3016–3025PubMedGoogle Scholar
  14. Cleary M, Dorfman RF, Sklar J (1986) Failure in immunological control of the virus: post-transplant lymphoma. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus: recent advances. Wiley, New YorkGoogle Scholar
  15. Countryman J, Jenson H, Seibl R, Wolfe H, Miller G (1987) Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses distrupt latency. J Virol 61: 3672–3679PubMedGoogle Scholar
  16. Dambaugh T, Biesel C, Hummel M (1980) Epstein-Barr virus (B95–8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci USA 77: 2999–3003PubMedCrossRefGoogle Scholar
  17. Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81: 7632–7636PubMedCrossRefGoogle Scholar
  18. Dillner J, Kallin B, Alexander H, Ernberg I, Uno M, Ono Y, Klein G, Lerner RA (1986) An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proc Natl Acad Sci USA 83: 6641–6645PubMedCrossRefGoogle Scholar
  19. DiMaio D, Corbin V, Sibley E, Maniatis T (1984) High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector. Mol Cell Biol 4: 340–350PubMedGoogle Scholar
  20. Drinkwater NR, Kleindinst DK (1986) Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency. Proc Natl Acad Sci USA 83: 3402–3406PubMedCrossRefGoogle Scholar
  21. DuBridge RB, Tang P, Hsia HC, Leong P-M, Miller JH, Calos MP (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379–387PubMedGoogle Scholar
  22. Epstein MA, Achong BG (1979) The relationship of the virus to Burkitt lymphoma. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 321–327CrossRefGoogle Scholar
  23. Feng S, Holland EC (1988) HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334: 165–167PubMedCrossRefGoogle Scholar
  24. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Feron DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514PubMedCrossRefGoogle Scholar
  25. Fischer DK, Robert MF, Shedd D, Summers WP, Robinson JE, Wolak J, Stefano JE, Miller G (1984) Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci USA 81:43–47PubMedCrossRefGoogle Scholar
  26. Frade R, Barel M, Ehlin-Henriksson B, Klein G (1985) gp140, The C3d receptor of human lymphocytes, is also the Epstein-Barr virus receptor. Proc Natl Acad Sci USA 82: 1490–1493PubMedCrossRefGoogle Scholar
  27. Fresen KO, Merkt G, Bornkamm GW, zur Hausen H (1977) Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction. Int J Cancer 19: 317–323PubMedCrossRefGoogle Scholar
  28. Gahn T, Schildkraut CL (1989) The Epstein-Barr virus origin of plasmid replication, ori P, contains both the initiation and termination sites of DNA replication. Cell 58: 527–535PubMedCrossRefGoogle Scholar
  29. Gerber P (1972) Activation of Epstein-Barr virus by 5-bromodeoxyuridine in “virus-tree” human cells. Proc Natl Acad Sci USA 69: 83–85PubMedCrossRefGoogle Scholar
  30. Glassy MC, Handley H, Hagiwara H, Royston I (1983) UC-729–6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci USA 80: 6327–6331PubMedCrossRefGoogle Scholar
  31. Gluzman Y (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175–182PubMedCrossRefGoogle Scholar
  32. Gluzman Y (ed) (1982) Eurkaryotic viral vectors. Cold Spring Harbor Laboratories, New YorkGoogle Scholar
  33. Gluzman Y, Hughes SH (eds) (1988) Eukaryotic viral vectors. Cold Spring Harbor Laboratories, New YorkGoogle Scholar
  34. Grogan E, Jensen H, Countryman J, Heston L, Gradoville L, Miller G (1987) Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc Natl Acad Sci USA 84: 1332–1336PubMedCrossRefGoogle Scholar
  35. Gussander E, Adams A (1984) Electron microscopic evidence for replication of circular Epstein-Barr virus genomes in latently infected Raji cells. J Virol 52: 549–556PubMedGoogle Scholar
  36. Haase SB, Heinzel SS, Krysan PJ, Calos MP (1989) Improved EBV shuttle vectors. Mutat Res 220: 125–132PubMedGoogle Scholar
  37. Hambor JE, Hauer CA, Shu H-K, Groger RK, Kaplan DR, Tykocinski ML (1988) Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone. Proc Natl Acad Sci USA 85: 4010–4014PubMedCrossRefGoogle Scholar
  38. Hammarskjold M-L, Wang S-C, Klein G (1986) High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector. Gene 43: 41–50PubMedCrossRefGoogle Scholar
  39. Hammerschmidt W, Sugden B (1988) Identification and characterization of ori lyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55: 427–433PubMedCrossRefGoogle Scholar
  40. Hampar B, Derge JG, Martos LM, Walker JL (1972) Synthesis of Epstein-Barr virus after activation of the viral genome in a “virus-negative” human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine. Proc Natal Acad Sci USA 69: 78–82CrossRefGoogle Scholar
  41. Hampar B, Tanaka A, Nonoyama M, Derge J (1974) Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells. Proc Natl Acad Sci USA 71: 631–633PubMedCrossRefGoogle Scholar
  42. Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166: 557–580PubMedCrossRefGoogle Scholar
  43. Heinzel SS, Krysan PJ, Calos MP, DuBridge RB (1988) Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J Virol 62: 3738–3746PubMedGoogle Scholar
  44. Heller R, Song K, Villaret D, Margolskee RF, Dunne J, Hayakawa H, Ringold GM (1990) Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries. J Biol Chem 264: 5708–5717Google Scholar
  45. Henle W, Henle G (1972) The relation of the Epstein-Barr virus to Burkitt’s lymphoma. In: Biggs RM, de-The G, Payne LN (eds) Oncogenesis and herpesviruses. IARC, LyonGoogle Scholar
  46. Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M (1970) Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169: 188–190PubMedCrossRefGoogle Scholar
  47. Henle W, Diehl V, Kohn G, ZurHausen H, Henle G (1987) Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157: 1064–1065CrossRefGoogle Scholar
  48. Hennessy K, Kieff E (1983) One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc Natl Acad Sci USA 80: 5665–5669PubMedCrossRefGoogle Scholar
  49. Hennessy K, Kieff E (1985) A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 277: 1238–1240CrossRefGoogle Scholar
  50. Hennessy K, Heller M, van Santen V, Kieff E (1983) Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science 220: 1396–1398PubMedCrossRefGoogle Scholar
  51. Hennessy K, Fennewald S, Kieff E (1985) A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus. Proc Natl Acad Sci USA 82: 5944–5948PubMedCrossRefGoogle Scholar
  52. Hennessy K, Wang F, Bushman EW, Kieff E (1986) Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family. Proc Natl Acad Sci USA 83: 5693–5697PubMedCrossRefGoogle Scholar
  53. Hieter P, Mann C, Snyder M, Davis RW (1985) Mitotic stability of yeast chromosomes: a colony color assay that measures nondisjunction and chromosome loss. Cell 40: 381–392PubMedCrossRefGoogle Scholar
  54. Hirt A (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365–369PubMedCrossRefGoogle Scholar
  55. Hsiung N, Fitts R, Wilson S, Milne A, Hamer D (1984) Efficient production of hepatitis B surface antigen using a bovine papilloma virus-metallothionein vectors. J Mol Appl Genet 2: 497–506PubMedGoogle Scholar
  56. Hudson GS, Bankier AT, Satchwell SC, Barrell BG (1985) The short unique region of the B95–8 Epstein-Barr virus genome. Virology 147: 81–98PubMedCrossRefGoogle Scholar
  57. Jalanko A, Kallio A, Salminen M, Ulmanen I (1989) Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vector. Gene 78: 287–296PubMedCrossRefGoogle Scholar
  58. Jenson HB, Farrell PJ, Miller G (987) Sequences of the Epstein-Barr virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA. J Virol 61: 1495–1506Google Scholar
  59. Kadesch T, Berg, P (1986) Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid. Mol Cell Biol 6: 2593–2601PubMedGoogle Scholar
  60. Kallin B, Dillner J, Ernberg I, Ehlin-Hendriksson B, Rosen A, Henle W, Henle G, Klein G (1986) Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci USA 83: 1499–1503PubMedCrossRefGoogle Scholar
  61. Kavathas P, Sukhatme V, Herzenberg LA, Parnes JR (1984) Isolation of the gene encoding the human T-lymphocyte differentiation antigen Leu-2 (T8) by gene transfer and cDNA subtraction. Proc Natl Acad Sci USA 81: 7688–7692PubMedCrossRefGoogle Scholar
  62. Kintner CR, Sugden B (1979) The structure of the termini of the DNA of Epstein-Barr virus. Cell 17: 661–671PubMedCrossRefGoogle Scholar
  63. Kioussis D, Wilson F, Daniels C, Leveton C, Taverne J, Playfiar JHL (1987) Expression and rescuing of a cloned human tumor necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J 6: 355–361PubMedGoogle Scholar
  64. Klein G (1979) The relationship of the virus to nasopharyngeal carcinomas. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 339–350CrossRefGoogle Scholar
  65. Krysan P, Haase S, Calos P (1989) Isolation of human sequences that replicate autonomously in human cells. Mol Cell Biol 9: 1026–1033PubMedGoogle Scholar
  66. Laux G, Freese UK, Fischer R, Polack A, Kofler E, Bornkamm GW (1988) TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 162: 503–507PubMedCrossRefGoogle Scholar
  67. Lebkowski JS, Clancy S, Calos MP (1985) Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 317: 169–171PubMedCrossRefGoogle Scholar
  68. Lehn H, Sauer G (1984) The physical state of hybrid genones containing simian virus 40 and bovine papilloma virus DNA sequences in transformed clonal cell lines. J Gen Virol 65: 1413–1418PubMedCrossRefGoogle Scholar
  69. Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF (1985) Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312: 1296–1299PubMedCrossRefGoogle Scholar
  70. Lindahl T, Adams A, Bjursell G, Bornkamm GW, Kaschka-Dierich B, Jehn V (1976) Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102:511–530PubMedCrossRefGoogle Scholar
  71. Littman DR, Thomas Y, Maddon PJ, Chess L, Axel R (1985) The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell 40: 237–246PubMedCrossRefGoogle Scholar
  72. Lombardi L, Newcomb EW, Della-Favera R (1987) Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B-lymphocytes. Cell 49: 161–170PubMedCrossRefGoogle Scholar
  73. Luka J, Kallin B, Klein G (1979) Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94: 228–231PubMedCrossRefGoogle Scholar
  74. Lupton S, Levine AJ (1985) Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cell. Mol Cell Biol 5: 2533–2542PubMedGoogle Scholar
  75. Lutfalla G, Armbruster L, Dequin S, Bertolotti R (1989) Construction of an EBNA-producing line of well differentiated human hepatoma cells and of appropriate Epstein-Barr virus based shuttle vectors. Gene 76: 27–39PubMedCrossRefGoogle Scholar
  76. Margolskee RF, Nathans D (1984) Simian virus 40 mutant T antigens with relaxed specificity for the nucleotide sequence at the viral DNA origin of replication. J Virol 49: 386–393PubMedGoogle Scholar
  77. Margolskee RF, Kavathas P, Berg P (1988) Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol Cell Biol 8: 2837–2847PubMedGoogle Scholar
  78. Mecsas J, Sugden B (1987) Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu Rev Cell Biol 3: 87–108PubMedCrossRefGoogle Scholar
  79. Miller G (1985) Epstein-Barr virus. In: Fields BN (ed) Virology. Raven, New York, pp 563–589Google Scholar
  80. Mitrani-Rosenbaum S, Maroteaux L, Mory Y, Revel M, Howley P (1983) Inducible expression of the human interferon β 1, gene linked to a bovine papilloma virus DNA vector and maintained extrachromosomally in mouse cells. Mol Cell Biol 3: 233–240PubMedGoogle Scholar
  81. Nonoyama M, Pagano JS (1972) Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus producing cells. Nature New Biol 238: 169–171PubMedCrossRefGoogle Scholar
  82. Oguro MO, Shimizu N, Ono Y, Takada K (1987) Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression. J Virol 61: 3310–3313PubMedGoogle Scholar
  83. Okayama H, Berg P (1982) High-efficiency cloning of full-length cDNA. Mol Cell Biol 2: 161–170PubMedGoogle Scholar
  84. Okayama H, Berg P (1983) A cDNA cloning vector that permits expression of cDNA inserts in mammalian cell. Mol Cell Biol 3: 280–289PubMedGoogle Scholar
  85. Okayama H, Berg P (1985) Bacteriophage lambda vector for transducing cDNA clone library into mammalian cell. Mol Cell Biol 5: 1136–1142PubMedGoogle Scholar
  86. Pattengale PK, Smith RW, Gerber P (1973) Selective transformation of B lymphocytes by EB virus. Lancet ii: 93–94CrossRefGoogle Scholar
  87. Pintel D, Merchlinsky MJ, Ward DC (1984) Expression of minute virus of mice structural proteins in murine cell lines transformed by bovine papillomavirus-minute virus of mice plasmid chimera. J Virol 52: 320–327PubMedGoogle Scholar
  88. Pope JH, Horne MK, Scott W (1968) Transformation of fetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 3: 857–866PubMedCrossRefGoogle Scholar
  89. Potter H, Weir L, Leder P (1984) Enchancer-dependent expression of human κ immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 81:7161–7165PubMedCrossRefGoogle Scholar
  90. Purtillo DT, Bhawan J, DeNicola L, Hutt LM, Szymanski I, Yang JPS, Boto W, Maier R, Thorley-Lawson D (1978) Epstein-Barr virus infections in the X-linked recessive lymphoproli-ferative syndrome. Lancet i: 798–802CrossRefGoogle Scholar
  91. Rawlins DR, Milman G, Hayward SD, Hayward GF (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42: 859–868PubMedCrossRefGoogle Scholar
  92. Razzaque A, Mizusuawa H, Seidman MM (1983) Rearrangement and mutagenesis of a shuttle vector plasmid after passage in mammalian cells. Proc Natl Acad Sci USA 80: 3010–3014PubMedCrossRefGoogle Scholar
  93. Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV) associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499–520PubMedCrossRefGoogle Scholar
  94. Reisman D, Sugden B (1986) trans Activation of an Epstein-Barr viral transcriptional enchancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 6: 3838–3846PubMedGoogle Scholar
  95. Reisman D, Yates J, Sugden B (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 5: 1822–1832PubMedGoogle Scholar
  96. Rooney CM, Rowe DT, Ragot T, Farrell PF (1989) The spliced BZLF1 gene a Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 63:3109–3116PubMedGoogle Scholar
  97. Shimizu N, Yamaki M, Sakuma S, Ono Y, Takada K (1988) Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA. Int J Cancer 41: 744–751PubMedCrossRefGoogle Scholar
  98. Shimizu Y, Koller B, Geraghty D, Orr H, Shaw S, Kavathas P, DeMars R (1986) Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells. Mol Cell Biol 6: 1074–1087PubMedGoogle Scholar
  99. Shortle D, Nathans D (1978) Local mutagenesis: a method for generating viral mutants with base substitutions in pre-selected regions of the viral genome. Proc Natl Acad Sci USA 75: 2170–2174PubMedCrossRefGoogle Scholar
  100. Shortle D, Nathan D (1979) Regulatory mutants of simian virus 40: constructed mutants with base substitutions at the origin of DNA replication. J Mol Biol 131: 801–817PubMedCrossRefGoogle Scholar
  101. Shortle D, Margolskee RF, Nathans D (1979) Mutational analysis of the simian virus 40 replicon: pseudorevertants of mutants with defective replication origin. Proc Natl Acad Sci USA 76:6128–6131PubMedCrossRefGoogle Scholar
  102. Skare J, Strominger JL (1980) Cloning and mapping of Bam HI endonuclease fragments of DNA from the transforming B95–8 strain of Epstein-Barr virus. Proc Natl Acad Sci USA 77:3860–3864PubMedCrossRefGoogle Scholar
  103. Skare J, Farley J, Strominger JL, Fresen KO, Cho MS, zur Hausen H (1985) Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragements Y and H. J Virol 55: 286–297PubMedGoogle Scholar
  104. Southern PJ, Berg P (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1: 327–341PubMedGoogle Scholar
  105. Speck SH, Strominger JL (1985) Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. Proc Natl Acad Sci USA 82: 8305–8309PubMedCrossRefGoogle Scholar
  106. Speck SH, Strominger JL (1987) Epstein-Barr virus transformation. Prog Nucleic Acid Res Mol Biol 34: 189–207PubMedCrossRefGoogle Scholar
  107. Strand BC, Schuster TC, Hopkins RF, Neubauer RH, Rabin H (1981) Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis. J Virol 38: 996–1004Google Scholar
  108. Sugden B (1984) Expression of virus-associated functions in cells transformed in vitro by Epstein-Barr virus: Epstein-Barr virus cell surface antigen and virus-release from transformed cells. In: Purtillo DT (ed) Immune deficiency and cancer, Epstein-Barr virus and lymphoproliferative malignancies. Plenum, New York, p 165Google Scholar
  109. Sugden B, Warren N (1988) Plasmid origin of replication of Epstein-Barr virus, ori P, does not limit replication in cis. Mol Biol Med 5: 85–94PubMedGoogle Scholar
  110. Sugden B, Warren N (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63: 2644–2649PubMedGoogle Scholar
  111. Sugden B, Phelps M, Domoradzki J (1979) Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31: 590–595PubMedGoogle Scholar
  112. Sugden B, Marsh K, Yates J (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 5: 410–413PubMedGoogle Scholar
  113. Summers WP, Grogan EA, Shedd D, Robert M, Lieu C-R, Miller G (1982) Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4 megadalton cloned fragment of Epstein-Barr virus DNA. Proc Natl Acad Sci USA 79: 5688–5692PubMedCrossRefGoogle Scholar
  114. Takada K (1984) Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33: 27–32PubMedCrossRefGoogle Scholar
  115. Takada K, zur Hausen H (1984) Induction of Epstein-Barr virus antigens by tumor promoters for epidermal and nonrepidermal tissues. Int J Cancer 33: 491–496PubMedCrossRefGoogle Scholar
  116. Takada K, Shimizu N, Ogura M, Oni Y (1986a) Identification of coding regions for various Epstein-Barr virus-specific antigens by gene transfer and serology. J Virol 60: 324–330PubMedGoogle Scholar
  117. Takada K, Shimizu N, Sakuma S, Ono Y (1986b) trans Activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57: 1016–102PubMedGoogle Scholar
  118. Tovy MG, Lenoir G, Begon-Lours J (1978) Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276: 270–272CrossRefGoogle Scholar
  119. Tykocinski ML, Shu H-K, Ayers DJ, Walter El, Getty RR, Groger RK, Hauer CA, Medof ME (1988) Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3′ end sequence of decay-accelerating factor’s mRNA. Proc Natl Acad Sci USA 85: 3555–3559PubMedCrossRefGoogle Scholar
  120. Wang Y, Stratowa C, Schaefer-Ridder M, Doehmer J, Hofschneider PH (1983) Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector. Mol Cell Biol 3: 1032–1039PubMedGoogle Scholar
  121. Weaver JF, McCormick F, Manos MM (1988) Production of recombinant human CSF-1 in an inducible mammalian expression system. Biotechnology 6: 287–290CrossRefGoogle Scholar
  122. Wysokenski D, Yates J (1989) Multiple EBNA-1 binding sites are required to form an EBNA-1 dependent enhancer and to activate a minimal replicative origin within ori P of Epstein-Barr virus. J Virol 63: 2657–2666PubMedGoogle Scholar
  123. Yates JL, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81: 3806–3810PubMedCrossRefGoogle Scholar
  124. Yates, JL, Warren N, Sugden B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812–815PubMedCrossRefGoogle Scholar
  125. Young JM, Cheadle C, Foulke JS Jr, Drohan WN, Sarver N (1988) Utilization of an Epstein-Barr virus replicon as a eurkaryotic expression vector. Gene 62: 171–185PubMedCrossRefGoogle Scholar
  126. Young RA, Davis R (1983) Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci USA 80: 1194–1198PubMedCrossRefGoogle Scholar
  127. Zinn K, DiMaio D, Maniatis T (1983) Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34: 865–879PubMedCrossRefGoogle Scholar
  128. zur Hausen H, O’Neill FJ, Freese UK, Hecker E (1978) Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature 272: 373–375PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin·Heidelberg 1992

Authors and Affiliations

  • R. F. Margolskee
    • 1
  1. 1.Department of NeurosciencesRoche Institute of Molecular Biology, Roche Research CenterNutleyUSA

Personalised recommendations